Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3306)	4/2/2001 4:32:31 PM
From: Jibacoa	of 52153

Apparently most people didn't like ONXX annual report, since it is down 20.5% today. biz.yahoo.com It seems their main problem is that at some time in the future they may have to start thinking about their expenditures.<g>: "Liquidity and Capital Resources:Since our inception, our cash expenditures have substantially exceeded our revenues". Their price is now substantially lower than the $10.849 per share Warner-Lambert paid earlier this month on a $5 million private placement. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next